Human Toxic Neuropathy Caused by Industrial Agents

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 2505-2525

  Berger, Alan R ^a   Schaumburg, Herbert H ^b  

^a UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36148944706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50115-0     Document Type: Chapter

References (174)

1. Aaserud O., Hommeren O.J., Tvedt B., et al. Carbon disulfide exposure and neurotoxic sequelae among viscose rayon workers. Am. J. Ind. Med. 1990, 18:25.
2. Alexeef G.V., Kilgore W.W. Methyl bromide. Residue Rev. 1983, 88:101.
3. Allen N., Mendell J.R., Billmaier D.J., et al. Toxic polyneuropathy due to methyln-butyl ketone: an industrial outbreak. Arch. Neurol. 1975, 32:209.
4. Alpers B.J., Lewey F.H. Changes in the nervous system following carbon disulfide poisoning in animals and man. Arch. Neurol. Psychiatry 1940, 44:725.
5. Altenkirch H., Mager J., Stoltenburg G., Helmbrecht J. Toxic polyneuropathies after sniffing a glue thinner. J. Neurol. 1977, 214:152.
6. Altenkirch H., Stoltenburg G., Haller D., et al. Clinical data on three cases of occupationally induced PCB-intoxication. Neurotoxicology 1996, 17:639.
7. Aring C.D. The systemic nervous affinity of triorthocresyl phosphate (Jamaica ginger palsy). Brain 1942, 65:34.
8. Baker T., Stanec A. Methylprednisone treatment of an organophosphorous-induced delay neuropathy. Toxicol. Appl. Pharmacol. 1985, 79:348.
9. Beauchamp R.O., Bus J.S., Popp J.A., et al. A critical review of the literature on carbon disulfide toxicity. CRC Crit. Rev. Toxicol. 1983, 11:169.
10. Besser R., Gutmann L., Dillman U., et al. End-plate dysfunction in acute organophosphate intoxication. Neurology 1989, 39:561.
11. Bouldin T.W., Cavanagh J.B. Organophosphorous neuropathy. 1. A teased-fiber study of the early stages of axonal degeneration. Am. J. Pathol. 1979, 94:253.
12. Branch R.A., Jacqz E. Subacute neurotoxicity following long-term exposure to carbaryl. Am. J. Med. 1986, 80:741.
13. Buiatti E., Cecchini S., Ronchi O., et al. Relationship between clinical and electromyographic findings and exposure to solvents, in shoe and leather workers. Br. J. Ind. Med. 1978, 35:168.
14. Buxton P.H., Hayward M. Polyneuritis cranialis associated with industrial trichlorethylene poisoning. J. Neurol. Neurosurg. Psychiatry 1967, 30:511.
15. Caroldi S., Lotti M., Masutti A. Intra-arterial injection of DFP or PMSF (phenylmethanesulfonyfluoride) produces respectively unilateral neuropathy or protection. Vet. Hum. Toxicol. 1982, 24:218.
16. Cavalleri F., Galassi G., Ferrari S., et al. Methyl bromide induced neuropathy: a clinical, neurophysiological, and morphological study. J. Neurol. Neurosurg. Psychiatry 1995, 58:383.
17. Cavanagh J.B. The toxic effect of tri-ortho-cresyl phosphate on the nervous system. J. Neurol. Neurosurg. Psychiatry 1954, 17:163.
18. Cavanagh J.B. Peripheral nerve changes in orthocresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 1964, 87:365.
19. Cavanagh J.B. The pathokinetics of acrylamide intoxication: a reappraisal of the problem. Neuropathol. Appl. Neurobiol. 1982, 8:315.
20. Cavanagh J.B., Gysbers M.F. Ultrastructural features of the Purkinje cell damage caused by acrylamide in the rat: a new phenomenon in cellular neuropathology. J. Neurocytol. 1983, 12:413.
21. Cavanagh J.B., Patangia G.N. Changes in the central nervous system in the cat as a result of tri-o-cresyl phosphate poisoning. Brain 1965, 88:165.
22. Chang Y.C. Neurotoxic effects of n-hexane on the human central nervous system: evoked potential abnormalities in n-hexane polyneuropathy. J. Neurol. Neurosurg. Psychiatry 1987, 50:269.
23. Chavez C.T., Hepler R.S., Straatsma B.R. Methyl bromide optic neuropathy. Am. J. Ophthalmol. 1985, 99:715.
24. Chia L., Chu F. Neurological studies on polychlorinated biphenyl (PCB)-poisoned patients. Am. J. Ind. Med. 1984, 5:117.
25. Chia L., Chu F. A clinical and electrophysiological study of patients with polychlorinated biphenyl poisoning. J. Neurol. Neurosurg. Psychiatry 1985, 48:894.
26. Chretien M., Patey G., Souyri F., Droz B. Acrylamide-induced neuropathy and impairment of axonal transport of proteins. II. Abnormal accumulations of smooth endoplasmic reticulum as sites of focal retention of fast transported proteins: electron microscopic radioautographic study. Brain Res. 1994, 205:15.
27. Clothier B., Johnson M.K. Rapid aging of neurotoxic esterase after inhibition by diisopropyl phosphorofluoridate. Biochem. J. 1979, 177:549.
28. Clothier B., Johnson M.K. Reactivation and aging of neurotoxic esterase inhibited by a variety of organophosphorous esters. Biochem. J. 1980, 185:739.
29. Cohen A.E., Scheel L.D., Kopp J.F., et al. Biochemical mechanisms in chronic carbon disulfide poisoning. Am. Ind. Hyg. J. 1959, 20:303.
30. Corsi G., Maestrelli P., Picotti G., et al. Chronic peripheral neuropathy in workers with previous exposure to carbon disulfide. Br. J. Ind. Med. 1983, 40:209.
31. Cranmer M.F. Carbaryl: a toxicological review and risk analysis. Neurotoxicology 1986, 7:247.
32. Dalvi R.R. Mechanism of the neurotoxic and hepatotoxic effects of carbon disulfide. Drug Metab. Drug Interact. 1988, 6:275.
33. DeBleecker J. The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. Clin. Toxicol. 1995, 33:683.
34. DeCaprio A.P., Briggs R.G., Jackowski S.J., Kim J.C.S. Comparative neurotoxicity and pyrrole-forming potential of 2, 5-hexanedione and perdeuterio-2,5-hexanedione in the rat. Toxicol. Appl. Pharmacol. 1988, 92:75.
35. DeCaprio A.P. n-Hexane, metabolites, and derivatives. Experimental and Clinical Neurotoxicology 2000, 633. Oxford University Press, New York. P.S. Spencer, H.H. Schaumburg (Eds.).
36. DeMatteis F., Seawright A.A. Oxidative metabolism of carbon disulfide by the rate: effect of treatments which modify the liver toxicity of carbon disulfide. Chem. Biol. Interact. 1973, 7:375.
37. Ecobichon D.J. Carbamic acid ester insecticides. Pesticides and Neurologic Diseases 1994, 251. CRC Press, Boca Raton, FL. 2nd ed. D.J. Ecobichon, R.M. Joy (Eds.).
38. Eskin T.A., Merigan W.H., Wood R.W. Carbon disulfide effects on the visual system: II: Retinogeniculate degeneration. Invest. Ophthalmol. Vis. Sci. 1988, 29:519.
39. Feldman R.G. Trichlorethylene. Handbook of Clinical Neurology, vol. 36: Intoxications of the Nervous System 1979, 457. North-Holland, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
40. Feldman R.G. Carbon disulfide. Occupational and Environmental Toxicology 1999, 400. Lippincott-Raven Publishers, Philadelphia.
41. Feldman R.G., White R.F., Currie J.N., et al. Long-term follow-up after single toxic exposure to trichloroethylene. Am. J. Ind. Med. 1985, 8:119.
42. Ferraz H.B., Bertolucci P.H.F., Pereira J.S., et al. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988, 38:550.
43. Fisher J.R. Guillain-Barre syndrome following organophosphate poisoning. JAMA 1977, 238:1950.
44. Freeman G., Epstein M.A. Therapeutic factors in survival after lethal cholinesterase inhibition by phosphorous insecticides. N. Engl. J. Med. 1955, 253:266.
45. Fujita A., Shibata M., Kato H., et al. Clinical observations on acrylamide poisoning. Nippon Iji Shimpo 1960, 1869:27.
46. Fullerton P.M., Barnes J.M. Peripheral neuropathy in rats produced by acrylamide. Br. J. Ind. Med. 1966, 23:210.
47. Gamier R., Rambourg-Schepens M.O., Muller A., Hallier E. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup. Environ. Med. 1996, 53:211.
48. Garland T.O., Paterson M.W.H. Six cases of acrylamide poisoning. Br. Med. J. 1967, 4:134.
49. von Genter St.Clair M.B., Amarnath V., Moody M.A., et al. Pyrrole oxidation and protein cross-linking as necessary steps in the development of γ-diketone neuropathy. Chem. Res. Toxicol. 1988, 1:179.
50. Gold B.G., Griffin J.W., Price D.L. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration. J. Neurosci. 1985, 5:1755.
51. Gold B.G., Halleck M.M. Axonal degeneration and axonal caliber alterations following combined β, β-iminodipropionitrile (IDPN) and acrylamide administration. J. Neuropathol. Exp. Neurol. 1989, 48:653.
52. Gold B.G., Schaumburg H.H. Acrylamide. Experimental and Clinical Neurotoxicology 2000, 124. Oxford University Press, New York. 2nd ed. P.S. Spencer, H.H. Schaumburg (Eds.).
53. Goldman L.R., Smith D.F., Neutra R.R., et al. Pesticide food poisoning from contaminated watermelons in California. Arch. Environ. Health 1990, 45:222.
54. Gordy S.T., Trumper M. Carbon disulfide poisoning with a report of six cases. JAMA 1938, 110:1543.
55. Gottfried M.R., Graham D.G, Morgan M., et al. The morphology of carbon disulfide neurotoxicity. Neurotoxicology 1985, 6:89.
56. Governa M., Calisti R., Coppa G., et al. Urinary excretion of 2, 5-hexanedione and peripheral polyneuropathies in workers exposed to hexane. J. Toxicol. Environ. Health 1987, 20:219.
57. Graham D.G., Amarnath V., Valentine W.M., et al. Pathogenic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 1995, 25:91.
58. Greenberg M.K., Swift T.R. Ethylene oxide peripheral neuropathy: four year follow-up. Muscle Nerve 1982, 5:557.
59. Grober E., Schaumburg H.H. High level occupational exposure to methyl isobutyl ketone causes permanent impairment in working memory. Neurology 2000, 54:1853.
60. Gross J.A., Haas M.L., Swift T.R. Ethylene oxide neuro-toxicity: report of four cases and review of the literature. Neurology (Minneap.) 1979, 29:978.
61. Hakkinen I., Siltanen E., Hernberg S.D., et al. Diphenyl poisoning in fruit paper production: a new health hazard. Arch. Environ. Health 1973, 26:70.
62. Harris C.H., Gulati A.K., Freidman M.A., Sickles D.W. Toxic neurofilamentous axonopathies and fast axonal transport. V. Reduced bi-directional vesicle transport in cultured neurons by acrylamide and glycidamide. J. Toxicol. Environ. Health 1994, 42:343.
63. Hashimoto K., Sakamoto J., Tanil H. Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch. Toxicol. 1981, 47:179.
64. He F., Jacobs J.M., Scaravilli F. The pathology of allyl chloride neurotoxicity in mice. Acta Neuropathol. 1981, 55:125.
65. He F., Lu B., Zhang S., et al. Chronic allyl chloride poisoning: an epidemiological, clinical, toxicological and neuropathological study. G. Ital. Med. Lav. 1985, 7:5.
66. He F., Zhang S., Wang H., et al. Neurological and electro-neuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand. J. Work Environ. Health 1989, 15:125.
67. Henschler D., Broser F., Hopf H.C. quot;Polyneuritis cranialis" following poisoning with chlorinated acetylenes while handling vinylidene chloride copolymers. Arch. Toxicol. 1970, 26:62.
68. Hern J.E.C., Hopkins A.P. Toxic neuropathy due to industrial agents. Peripheral Neuropathy 2nd ed. 1975, II:1213. W. B. Saunders, Philadelphia. P.J. Dyck, P. K. Thomas, E.H. Lambert (Eds.).
69. Herskowitz A., Ishii N., Schaumburg H.H. n-Hexane neuropathy: a syndrome occurring as a result of industrial exposure. N. Engl. J. Med. 1971, 285:82.
70. Herzstem J., Cullen M.R. Methyl bromide intoxication in four field workers during removal of soil fumigation sheets. Am. J. Ind. Med. 1990, 17:21.
71. Hollingsworth R.L., Rowe U.K., Oyene F. Toxicity of ethylene oxide determined on experimental animals. Arch. Ind. Health 1956, 13:217.
72. Hunter A., Neal R.A. Response of the hepatic mixed function oxidase enzyme system to thionosulfur-containing compounds. Pharmacologist 1974, 16:239.
73. Igisu H., Goto I., Kawamura Y., et al. Acrylamide encephalopathy due to well water pollution. J. Neurol. Neurosurg. Psychiatry 1975, 38:581.
74. Israeli R., Sculsky M., Tiberin P. Acute intoxication due to exposure to maneb and zineb: a case with behavioral and central nervous system changes. Scand. J. Work Environ. Health 1983, 9:47.
75. Jakobsen J., Sidenius P. Early and dose-dependent decrease of retrograde axonal transport in acrylamide-intoxicated rats. J. Neurochem. 1983, 40:447.
76. Jedrzejowsha H., Rowinska-Marcinska K., Hoppe B. Neuropathy due to phytosol (Agritox): report of a case. Acta Neuropathol. (Berl.) 1980, 49:163.
77. Johnson B.L., Anger W.K., Setzer J.V., et al. Neurobehavioral effects of methyln-butyl ketone and methyln-amyl ketone in rats and monkeys: summary of NIOSH investigators 1978, Pathotox Publishers, Chicago, Proceedings 1st Annual NIOSH Scientific Symposium: Toxicological and Carcinogenic Health Hazards in the Workplace.
78. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphate ester: biochemical studies and toxicological applications. Rev. Biochem. Toxicol. 1982, 4:141.
79. Johnson M.K. Receptor or enzyme: the puzzle of NTE and organophosphate-induced delayed polyneuropathy. Trends Pharmacol. Sci. 1987, 8:174.
80. Johnson M.K. Contemporary issues in toxicology. Organophosphates and delayed neuropathy-is NTE alive and well?. Toxicol. Appl. Pharmacol. 1990, 102:385.
81. Juntunen J., Linnoila I., Haltia M. Histochemical and electron microscopic observations on the myoneural junctions of rats with carbon disulfide induced polyneuropathy. Scand. J. Work Environ. Health 1977, 3:36.
82. Kane F.J. Carbon disulfide intoxication from overdose of disulfiram. Am. J. Psychiatry 1970, 127:690.
83. Kantarjian A.D., Shaheen A.S. Methyl bromide poisoning with nervous system manifestations resembling polyneuropathy. Neurology 1963, 13:1054.
84. Kid J.G., Langworthy O.R. Paralysis following the injection of Jamaica ginger extract adulterated with triorthocresyl phosphate. Johns Hopkins Med. J. 1933, 52:39.
85. Kimbrough R.O., Doemland M.L., Krouskzs C.A. Analysis of research studying the effects of polychlorinated biphenyls and related chemicals on neurobehavioral development in children. Vet. Hum. Toxicol. 2001, 43:330.
86. Knave B., Kolmodin-Hedman B., Persson H.E., Goldberg J.M. Chronic exposure to carbon disulfide: effects on occupationally exposed workers with special reference to the nervous system. Work Environ. Health 1974, 11:49.
87. Korobkin R., Asbury A.K., Sumner A.J., Nielsen S.L. Glue-sniffing neuropathy. Arch. Neurol. 1975, 32:158.
88. Lawrence W.H., Partyka E.K. Chronic dysphagia and trigeminal anesthesia after trichloroethylene exposure. Ann. Intern. Med. 1981, 95:710.
89. LeQuesne P.M. Neurophysiological investigation of subclinical and minimal toxic neuropathies. Muscle Nerve 1978, 1:392.
90. LeWitt P. The neurotoxicity of the rat poison Vacor. N. Engl. J. Med. 1980, 302:73.
91. Lieben J., Williams R.A. Five years of experience with CS2. Behavioral Toxicology: Early Detection of Occupational Hazards (HEW Pub. No. [NIOSH] 74-126). Washington, DC, U.S. Dept. of Health 1974, 50. and Welfare, Education. C. Xintras, B.L. Johnson, I. deGroot (Eds.).
92. Linnoila I., Haltia M., Seppalainen A.M., Palo J. Experimental carbon disulfide poisoning: morphological and neurophysiological studies. Proceedings of the VII International Congress of Neuropathology 1975, 383. Excerpta Medica Foundation, Amsterdam. S. Kornyey, S. Tarishka, G. Gosztonyi (Eds.).
93. LoPachin R.M., Castiglia C.M., Saubermann A.J. Acrylamide disrupts elemental composition and water content of rat tibial nerve. I. Myelinated axons. Toxicol. Appl. Pharmacol. 1992, 115:21.
94. LoPachin R.M., Castiglia C.M., Saubermann A.J. Acrylamide disrupts elemental composition and water content of rat tibial nerve. II. Schwann cells and myelin. Toxicol. Appl. Pharmacol. 1992, 115:35.
95. LoPachin R.M., Lehning E.J. Acrylamide induced distal axon degeneration: a proposed mechanism of action. Neurotoxicology 1994, 15:247.
96. LoPachin R.M., Lehning E.J., Stack E.C., et al. 2, 5-Hexanedione alters elemental composition and water content of rat peripheral nerve myelinated axons. J. Neurochem. 1994, 63:2266.
97. Lotti M. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem. Biol. Interact. 1999, 119-120:519.
98. Lotti M. Low-level exposure to organophosphorous esters and peripheral nerve function. Muscle Nerve 2002, 25:492.
99. Lotti M., Becker C.E., Aminoff M.J. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 1984, 34:658.
100. Lotti M., Moretto A., Capodicase E., et al. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol. Appl. Pharmacol. 1993, 122:165.
101. Lotti M., Moretto A., Zoppellari R., et al. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneur-opathy. Arch. Toxicol. 1986, 59:176.
102. Lowndes H.E., Baker T., Riker W.F. Motor nerve dysfunction in delayed DFP neuropathy. Wur. J. Pharmacol. 1974, 29:66.
103. Lynch J.J., Merigan W.H., Eskin T.A. Subchronic dosing of macaques with 2, 5-hexanedione causes long-lasting motor dysfunction but reversible visual loss. Toxicol. Appl. Pharmacol. 1989, 98:166.
104. Manu P., Lancranjan I., Zamfirescu M. Investigation of serum LDH and its isoenzymatic model in carbon disulfide polyneuritis. Int. Arch. Arbeitsmed. 1970, 26:45.
105. Maurissen J.P., Weiss B., Cox C. Vibration sensitivity recovery after a second course of acrylamide intoxication. Fund. Appl. Toxicol. 1990, 15:93.
106. Medrano C.J., LoPachin R.M. Effects of acrylamide and 2, 5-hexanedione on brain mitochondrial respiration. Neurotoxicology 1989, 10:249.
107. Metcalf D.R., Holmes J.H.V. Toxicology and physiology: EEG, psychological and neurological alterations in humans with organophosphorous exposure. Ann. N. Y. Acad. Sci. 1969, 160:357.
108. Meuling W.J., Bragt P.D., Braun C.L. Biological monitoring of carbon disulfide. Am. J. Ind. Med. 1990, 17:247.
109. Miller M.S., Miller M.J., Burks T.F., Sipes I.G. Altered retrograde axonal transport of nerve growth factor after single and repeated doses of acrylamide in the rat. Toxicol. Appl. Pharmacol. 1983, 69:96.
110. Miller M.S., Spencer P.S. Single doses of acrylamide reduce retrograde transport velocity. J. Neurochem. 1984, 43:1401.
111. Moretto A., Bertolazzi M., Lotti M. The phosphorothioic acid-O-(2-chloro-2, 3, 3-trifluorocyclobutyl)-O-ethyl S-propyl ester promotes organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicol. Appl. Pharmacol. 1994, 129:133.
112. Moretto A., Lotti M., Sabri M.I., Spencer P.S. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J. Neurochem. 1987, 49:1515.
113. Moretto A., Lotti M., Spencer P.S. In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2-2-dichlorovinyl phosphate. Arch. Toxicol. 1989, 63:469.
114. Moses H., Klawans H.L. Bromide intoxication. The Handbook of Clinical Neurology 1979, 291. Amsterdam, Elsevier. P.J. Vinken, G.W. Bruyn (Eds.).
115. Munch G., Lincoln J., Maynard K.I., et al. Effects of acrylamide on cotransmission in perivascular sympathetic and sensory nerves. J. Auton. Nerv. Syst. 1994, 49:197.
116. Murai Y., Kuroiwa Y. Peripheral neuropathy in chlorobiphenyl poisoning. Neurology 1971, 21:1173.
117. Myers J.E. Acrylamide neuropathy in a South African factory: an epidemiologic investigation. Am. J. Ind. Med. 1991, 19:487.
118. Nagata H., Ohkoshi N., Kanazawa I., et al. Rapid axonal transport velocity is reduced in experimental ethylene oxide neuropathy. Med. Chem. Neuropathol. 1992, 17:209.
119. Nishimura M., Urneda M., Ishizu S., Sato M. Effect of methyl bromide on cultured mammalian cells. J. Toxicol. Sci. 1980, 5:321.
120. Noseworthy J.H., Rice G.P.A. Trichloroethylene poisoning mimicking multiple sclerosis. Can. J. Neurol. Sci. 1988, 15:87.
121. Ogawa M. Electrophysiological and histological studies of experimental chlorobiphenyl poisoning. FGBRuoka Acts Med. 1971, 62:74.
122. Ohnishi A. Ethylene oxide. Experimental and Clinical Neurotoxicology 2000, 563. Oxford University Press, New York. P.S. Spencer, H.H. Schaumburg (Eds.).
123. Ohnishi A., Inoue N., Yamamoto T., et al. Ethylene oxide neuropathy in rats: exposure to 250 ppm. J. Neurol. Sci. 1986, 74:215.
124. Ohnishi A., Yamamoto T., Murai Y., et al. Propylene oxide causes central-peripheral distal axonopathy in rats. Arch. Environ. Health 1988, 43:353.
125. Osterloh J., Lotti M., Pond S.M. Toxicologic studies in a fatal overdose of 2, 4-D, MCPP and chlorpyrifos. J. Anal. Toxicol. 1983, 7:125.
126. Osterman J., Zmyslinski R.W., Hopkins C.B., et al. Full recovery from severe orthostatic hypotension after Vacor rodenticide ingestion. Arch. Intern. Med. 1981, 141:1505.
127. Perbellini L., DeGrandis D., Semenzato F., et al. An experimental study on the neurotoxicity of n-hexane metabolites: hexanol-1 and hexanol-2. Toxicol. Appl. Pharmacol. 1978, 46:421.
128. Politis M.I., Pellegrino R.G., Spencer P.S. Ultrastructural studies of the dying-back process. 5. Axonal neurofilaments accumulate at sites of 2, 5-hexanedione application: evidence of nerve fibre dysfunction in experimental hexacarbon neuropathy. J. Neurocytol. 1980, 9:505.
129. Post E.J., McLeod J.G. Acrylamide autonomic neuropathy in the cat. Part I. Neurophysiological and histological studies. J. Neurol. Sci. 1977, 33:353.
130. Post E.J., McLeod J.G. Acrylamide autonomic neuropathy in the cat. Part II. Effects on mesenteric vascular control. J. Neurol. Sci. 1977, 33:375.
131. Prineas J. The pathogenesis of dying-back polyneuropathies. Part I. An ultrastructural study of experimental tri-orthocresyl phosphate intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:571.
132. Prineas J. The pathogenesis of dying-back polyneuropathies. Part II. An ultrastructural study of experimental acrylamide intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:598.
133. Rebert C.S., Becker E. Effects of inhaled carbon disulfide on sensory-evoked potentials of Long-Evans rats. Neurobehav. Toxicol. Teratol. 1986, 8:533.
134. Rice J.M., Wilbourn J.D. Tumors of the nervous system in carcinogenic hazard identification. Toxicol. Pathol. 2000, 28:202.
135. Rosenberg C.K., Genter M.B., Szakal-Quin G., et al. d, l-Versus meso- 3, 4-dimethyl-2, 5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. Toxicol. Appl. Pharmacol. 1986, 87:363.
136. Saunders R.A. A new hazard in closed environmental atmospheres. Arch. Environ. Health 1967, 14:380.
137. Schaumburg H.H., Arezzo J.C., Spencer P.S. Delayed onset of distal axonal neuropathy in primates after prolonged low-level administration of a neurotoxin. Ann. Neurol. 1989, 26:576.
138. Schaumburg H.H., Spencer P.S. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science 1978, 199:199.
139. Schaumburg H.H., Spencer P.S. Clinical and experimental studies of distal axonopathy-a frequent form of brain and nerve damage produced by environmental chemical hazards. Ann. N. Y. Acad. Sci. 1979, 329:14.
140. Schaumburg H.H., Wisniewski H.M., Spencer P.S. Ultra-structural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J. Neuropathol. Exp. Neurol. 1974, 33:260.
141. Scheel L.D. Biological changes involving metal ion shifts. Am. Ind. Hyg. Assoc. J. 1965, 26:585.
142. Schell J.D., Budinsky R.A., Wernke M.J. PCB's and neurodevelopmental effects in Michigan children: an evaluation of exposure and dose characterization. Reg. Toxicol. Pharmacol. 2001, 33:300.
143. Seppalainen A.M., Haltia M. Carbon disulfide. Experimental and Clinical Neurotoxicology 1980, 356. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
144. Seppalainen A.M., Linnoila I. Electrophysiological findings in rats with experimental carbon disulfide neuropathy. Neuropathol. Appl. Neurobiol. 1976, 2:209.
145. Seppalainen A.M., Tolonen M. Neurotoxicity of long-term exposure to carbon disulfide in the viscose rayon industry: a neurophysiologic study. Work Environ. Health 1974, 11:145.
146. Seppalainen A.M., Vuojolahti P., Elo O. Reversible nerve lesions after accidental polychlorinated biphenyl exposure. Scand. J. Work Environ. Health 1985, 11:91.
147. Shore R.E., Gardner M.J., Pannett B. Ethylene oxide: an assessment of the epidemiologic evidence on carcinogenicity. Br. J. Ind. Med. 1993, 50:971.
148. Sickles D.W., Fowler S.R., Testino A.R. Effects of neuro-filamentous axonopathy-producing neurotoxicants on in-vitro production of ATP by brain mitochondria. Brain Res. 1990, 528:25.
149. Sidenius P., Jakobsen J. Anterograde axonal transport in rats during intoxication with acrylamide. J. Neurochem. 1983, 40:697.
150. Smith H.V., Spalding J.M.K. Outbreak of paralysis in Morocco due to orthocresyl phosphate poisoning. Lancet 1959, 2:1019.
151. Spencer P.S., Butterfield P. Environmental agents and Parkinson's disease. Etiology of Parkinson's Disease 1995, 319. Marcel Dekker, New York. H.J. Ellenberg, R. Koller (Eds.).
152. Spencer P.S., Sabri M.I., Schaumburg H.H., Moore C.L. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann. Neurol. 1979, 5:501.
153. Spencer P.S., Schaumburg H.H. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can. J. Neurol. Sci. 1974, 1:143.
154. Spencer P.S., Schaumburg H.H. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 1977, 36:276.
155. Spencer P.S., Schaumburg H.H. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J. Neuropathol. Exp. Neurol. 1977, 36:300.
156. Squier M.V., Thompson J., Rajgopalan B. Case report: neuro-pathology of methyl bromide intoxication. Neuropathol. Appl. Neurobiol. 1992, 18:579.
157. Sterman A.B. Altered sensory ganglia in acrylamide neuropathy: quantitative evidence of neuronal reorganization. J. Neuropathol. Exp. Neurol. 1983, 42:166.
158. Sterman A.B. Acrylamide-induced remodeling of perikarya in rat superior cervical ganglia. Neuropathol. Appl. Neurobiol. 1984, 10:221.
159. Sumner A.J., Asbury A.K. Physiological studies of the dying-back phenomenon: muscle stretch afferents in acrylamide neuropathy. Brain 1975, 98:91.
160. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 1992, 5:81.
161. Szendzikowski S., Stetkiewicz J., Wronska-Nofer T., Zdrajkowska I. Structural aspects of experimental carbon disulfide neuropathy. I. Development of the neurohistological changes in chronically intoxicated rats. Int. Arch. Arbeitsmed. 1973, 31:135.
162. Takahashi A., Mizutani M., Agr B., et al. Acrylamide-induced neurotoxicity in the central nervous system of Japanese quails. J. Neuropathol. Exp. Neurol. 1994, 53:276.
163. Tilson H.A. The neurotoxicity of acrylamide: an overview. Neurobehav. Toxicol. Teratol. 1981, 3:445.
164. Tornquist H.L., Nordander C., Rosen I., et al. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand. J. Work Environ. Health 2001, 27:219.
165. Vasilescu C. Sensory and motor conduction in chronic carbon disulfide poisoning. Eur. Neurol. 1976, 14:447.
166. Veronesi B., Peterson E.R., Bornstein M.B., Spencer P.S. Ultra-structural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture. J. Neuropathol. Exp. Neurol. 1983, 42:153.
167. Vigliani E.C. Carbon disulfide poisoning in viscose rayon factories. Br. J. Ind. Med. 1954, 11:235.
168. Wadia R.S., Chitra S., Amin R.B., et al. Electrophysiologic studies in acute organophosphate poisoning. J. Neurol. Neurosurg. Psychiatry 1987, 50:1442.
169. Wadia R.S., Sadagopan C., Amin R.B., Sardesai H.V. Neurological manifestations of organophosphorous insecticide poisoning. J. Neurol. Neurosurg. Psychiatry 1974, 37:841.
170. Watson D.F., Griffin J.W. Vacor neuropathy: ultra-structural and axonal transport studies. J. Neuropathol. Exp. Neurol. 1987, 46:96.
171. Williams D.G. Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. Biochem. J. 1983, 209:817.
172. Windebank A.J., Blexrud M.D. Residual ethylene oxide in hollow fiber hemodialysis units is neurotoxic in vitro. Ann. Neurol. 1989, 26:63.
173. Windebank A.J., Blexrud M.D., de Groen P.C. Potential neurotoxicity of the solvent vehicle for cyclosporine. J. Pharmacol. Exp. Ther. 1994, 268:1051.
174. Zhu M., Spink D.C., Yan B., et al. Formation and structure of crosslinking and monomeric pyrrole autoxidation products in 2, 5-hexanedione-treated amino acids, peptides, and protein. Chem. Res. Toxicol. 1974, 7:551.